Zhejiang CONBA Pharmaceutical Co.,Ltd. (600572.SS)

CNY 4.77

(0.0%)

EBITDA Summary of Zhejiang CONBA Pharmaceutical Co.,Ltd.

  • Zhejiang CONBA Pharmaceutical Co.,Ltd.'s latest annual EBITDA in 2023 was 1.12 Billion CNY , up 11.46% from previous year.
  • Zhejiang CONBA Pharmaceutical Co.,Ltd.'s latest quarterly EBITDA in 2024 Q3 was 169.85 Million CNY , down -39.92% from previous quarter.
  • Zhejiang CONBA Pharmaceutical Co.,Ltd. reported an annual EBITDA of 916.96 Million CNY in 2022, down -69.14% from previous year.
  • Zhejiang CONBA Pharmaceutical Co.,Ltd. reported an annual EBITDA of 2.88 Billion CNY in 2021, up 173.4% from previous year.
  • Zhejiang CONBA Pharmaceutical Co.,Ltd. reported a quarterly EBITDA of 289.09 Million CNY for 2024 Q1, up 402.94% from previous quarter.
  • Zhejiang CONBA Pharmaceutical Co.,Ltd. reported a quarterly EBITDA of 169.85 Million CNY for 2024 Q3, down -39.92% from previous quarter.

Annual EBITDA Chart of Zhejiang CONBA Pharmaceutical Co.,Ltd. (2023 - 2001)

Historical Annual EBITDA of Zhejiang CONBA Pharmaceutical Co.,Ltd. (2023 - 2001)

Year EBITDA EBITDA Growth
2023 1.12 Billion CNY 11.46%
2022 916.96 Million CNY -69.14%
2021 2.88 Billion CNY 173.4%
2020 1.23 Billion CNY 13.13%
2019 490.95 Million CNY -14.13%
2018 1.37 Billion CNY 15.21%
2017 1.17 Billion CNY 22.73%
2016 874 Million CNY 0.35%
2015 919 Million CNY -8.13%
2014 1.06 Billion CNY 44.95%
2013 711.03 Million CNY 25.37%
2012 534.26 Million CNY 23.9%
2011 370.69 Million CNY 49.24%
2010 320.47 Million CNY 72.45%
2009 175.79 Million CNY 42.34%
2008 181.85 Million CNY -49.18%
2007 253.77 Million CNY 85.51%
2006 139.31 Million CNY 16.56%
2005 119.79 Million CNY 18.92%
2004 100.92 Million CNY 54.65%
2003 64.98 Million CNY -10.19%
2002 72.36 Million CNY 3.28%
2001 70.06 Million CNY 0.0%

Peer EBITDA Comparison of Zhejiang CONBA Pharmaceutical Co.,Ltd.